Education
About Us
Working with TipRanks
Follow Us
Inspire Medical (INSP)
:INSP
INSP Stock Chart & Stats
$96.54
-$1.46(-0.68%)
At close: 4:00 PM EST
$96.54
-$1.46(-0.68%)
Day’s Range― - ―
52-Week Range$70.77 - $216.01
Previous CloseN/A
Volume95.34K
Average Volume (3M)1.92M
Market Cap
$2.81B
Enterprise Value$1.91B
Total Cash (Recent Filing)$322.59M
Total Debt (Recent Filing)$32.58M
Price to Earnings (P/E)66.2
Beta0.43
Next Earnings
Feb 10, 2026EPS Estimate
0.68Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.38
Shares Outstanding29,056,435
10 Day Avg. Volume2,740,515
30 Day Avg. Volume1,923,743
Financial Highlights & Ratios
PEG Ratio-0.29
Price to Book (P/B)8.00
Price to Sales (P/S)6.87
P/FCF Ratio60.55
Enterprise Value/Market Cap0.68
Enterprise Value/Revenue2.16
Enterprise Value/Gross Profit2.54
Enterprise Value/Ebitda24.88
Forecast
1Y Price Target
$142.33Price Target Upside47.43% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering18
EPS Forecast (FY)1.6
Revenue Forecast (FY)$905.25M
Bulls Say, Bears Say
Bulls Say
Advertising And Revenue GrowthIncreased advertising expense should help drive patient volume.
Competitive PositionThe competitive landscape is favorable for Inspire Medical, with LivaNova's independent approach and Nyxoah's slow start.
Reimbursement UpdateInspire Medical received a significant reimbursement increase, which is expected to benefit the company financially.
Bears Say
Code Removal ImpactShares of INSP have dropped significantly following the removal of CPT 64568 as an acceptable code by a Medicare Administrative Contractor.
Competition And Market ShareIncoming HGNS competition could limit INSP's ability to accelerate sales growth, with potential market share declines expected.
Inconsistent PoliciesThe lack of a broader National Coverage Determination for hypoglossal nerve stimulation leads to inconsistent policies across different Medicare Administrative Contractors.
Inspire Medical Systems News
INSP FAQ
What was Inspire Medical’s price range in the past 12 months?
Inspire Medical lowest stock price was $70.77 and its highest was $216.01 in the past 12 months.
What is Inspire Medical’s market cap?
Inspire Medical’s market cap is $2.81B.
When is Inspire Medical’s upcoming earnings report date?
Inspire Medical’s upcoming earnings report date is Feb 10, 2026 which is in 49 days.
How were Inspire Medical’s earnings last quarter?
Inspire Medical released its earnings results on Nov 03, 2025. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of -$0.189 by $0.569.
Is Inspire Medical overvalued?
According to Wall Street analysts Inspire Medical’s price is currently Undervalued.
Does Inspire Medical pay dividends?
Inspire Medical does not currently pay dividends.
What is Inspire Medical’s EPS estimate?
Inspire Medical’s EPS estimate is 0.68.
How many shares outstanding does Inspire Medical have?
Inspire Medical has 29,056,435 shares outstanding.
What happened to Inspire Medical’s price movement after its last earnings report?
Inspire Medical reported an EPS of $0.38 in its last earnings report, beating expectations of -$0.189. Following the earnings report the stock price went up 15.33%.
Which hedge fund is a major shareholder of Inspire Medical?
Currently, no hedge funds are holding shares in INSP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Inspire Medical Systems Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$142.33 (47.43% Upside)
$142.33 (47.43% Upside)
Blogger Sentiment
Bullish
INSP Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 877.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $188.1 over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 1.7%
Last 30 Days ▲ 1.4%
Last 30 Days ▲ 1.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-47.93%
12-Months-Change
Fundamentals
Return on Equity
6.54%
Trailing 12-Months
Asset Growth
1.45%
Trailing 12-Months
Company Description
Inspire Medical
Inspire Medical Systems, Inc. is a medical technology company focused on developing innovative solutions for patients suffering from obstructive sleep apnea (OSA). The company's primary product is the Inspire therapy system, an implanted device that delivers neurostimulation to key airway muscles to maintain an open airway during sleep. Inspire Medical Systems operates in the healthcare sector, specifically within sleep medicine, and is dedicated to improving the quality of life for patients with OSA through its advanced medical devices.
INSP Company Deck
INSP Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue growth and improved gross margins, driven by the successful launch and adoption of Inspire V and positive clinical outcomes. However, these positives were somewhat offset by increased operating expenses and decreased net income compared to the prior year. The company remains optimistic with increased earnings guidance and improved reimbursement outlook.View all INSP earnings summariesINSP Revenue Breakdown
97.02% U.S.
2.98% Other
INSP Stock 12 Month Forecast
Average Price Target
$142.33
▲(47.43% Upside)
Technical Analysis
Integer Holdings
―
LivaNova
―
Irhythm Technologies
―
TransMedics Group
―
PROCEPT BioRobotics
―
Ownership Overview
Currently, No data available
---